Individualization of Immunosuppressive Therapy. III. Sirolimus Associated With a Reduced Incidence of Malignancy

Renal transplant recipients treated with the sirolimus-CsA ± Pred combination showed a low incidence of tumors of similar types as those encountered with other regimens.